Host: Peter Buch, MD, FACG, AGAF, FACP

Guest: William Grady, MD

While colorectal cancer is the second most common cause of cancer deaths, only a third of people between the ages of 45 and 75 are compliant with screening recommendations. However, cell-free DNA blood-based tests could become a new option for colorectal cancer screening. Dr. Peter Buch sits down with GI expert Dr. William Grady to discuss the efficacy of this new test and where it is in the FDA approval process.

Podden och tillhörande omslagsbild på den här sidan tillhör ReachMD. Innehållet i podden är skapat av ReachMD och inte av, eller tillsammans med, Poddtoppen.